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Introduction {#sec005}
============

Current treatment of locally advanced laryngeal cancer/hypopharyngeal cancer has gradually evolved to the strategy of concurrent chemoradiotherapy (CRT). However, total laryngectomy still plays a role in primary advanced T4 laryngeal/hypopharyngeal cancer, in persistent or recurrent tumors after primary radiation (RT) for salvage purposes, or in a non-functional larynx after previous treatment \[[@pone.0236122.ref001]--[@pone.0236122.ref003]\]. Postoperative wound complications and prolonged hospital stay are important issues in primary and salvage total laryngectomy (TL) \[[@pone.0236122.ref004], [@pone.0236122.ref005]\]. When postoperative major wound complications occur among patients with head and neck squamous cell carcinoma (HNSCC), it delays adjuvant therapy, prolongs hospital stay, increases medical expense, and induces a higher risk of psychological distress among patients. There are several factors related to wound complications, including previous history of CRT/RT, poor nutrition status, anemia, neck dissection, and tumor stage. Currently, it will be worthwhile to realize the factors about the prolonged hospital length of stay (LOS) and higher total inpatient medical cost among patients undergoing total laryngectomy. Therefore, the aim of this study is to determine the predictive factors of postoperative prolonged hospital LOS and higher inpatient medical cost among patients undergoing total laryngectomy.

Materials and methods {#sec006}
=====================

Study population {#sec007}
----------------

Patients who underwent total laryngectomy with or without microvascular free flap reconstruction were enrolled retrospectively from the institutional cancer database between January 2009 and May 2018 in Kaohsiung Chang Gung Memorial hospital, Taiwan. Free flap transfer for pharyngeal defect reconstruction after total laryngectomy would be performed if pharyngeal defect couldn't primarily close without tension. Patients who received partial laryngectomy or partial laryngopharyngectomy or patient didn't receive total laryngectomy surgical procedure in our hospital would be excluded from our study. Treatment was primarily based on the American National Comprehensive Cancer Network (NCCN) guidelines.

Peri-operative clinical variables of interest were collected, including age; sex; performance status ([Eastern Cooperative Oncology Group](https://en.wikipedia.org/wiki/Eastern_Cooperative_Oncology_Group) (ECOG) score); primary tumor location and histology; body mass index (BMI); pre-operative serum hemoglobin; pre- and post-operative serum albumin; post-operative serum hemoglobin; past medical history, including diabetes mellitus and liver cirrhosis; prior interventions such as RT and CRT; and reason for TL (i.e., primary tumor, salvage treatment for persistent or recurrent cancer, or non-functional larynx). Operative details, including completion of neck dissection(s) and method of pharyngeal closure (primary closure, use of free tissue reconstruction), were also included. Post-operative wound complications, LOS, and inpatient medical cost were also reviewed.

Variables and outcomes {#sec008}
----------------------

Patients were retrospectively enrolled according to the following clinical characteristics: gender, age, primary tumor site, post-operative wound condition, length of hospital stay, and total medical cost of this hospitalization. BMI and circulatory laboratory data, including serum hemoglobin and serum albumin, were regularly measured within 1 week before the surgery. Postoperative serum hemoglobin is defined as the serum hemoglobin level collected the morning after the surgery. Postoperative serum albumin is defined as the serum albumin level collected the morning after the surgery. Anemia is defined as serum hemoglobin level \< 13 g/dL. Hypoalbuminemia is defined as serum albumin level \< 3.5 g/dL. Patients with liver cirrhosis presenting as Child-Pugh C classification were excluded from analysis. Major postoperative wound infection is defined as a postoperative recipient-site wound condition that necessitated wound debridement in the operating room. Length of hospital stay after surgery is defined as the period between the operation and discharge from the ward in this study.

Statistical analysis {#sec009}
--------------------

Statistical analyses were performed using SPSS 20.0 software (SPSS/IBM, Inc., Chicago, IL). The endpoints of this study included major postoperative wound infection, length of hospital stay after surgery, and inpatient total medical cost of this hospitalization. A mean and median approach was applied to select appropriate thresholds for hospital stay and medical cost. Pearson's chi-squared test was used to determine whether there was a significant difference between each selected clinical factor and the outcome we were interested in, such as postoperative major wound infection, postoperative length of hospital stay, and inpatient total medical cost. Logistic regression analyses were performed to reveal the relationship between postoperative length of hospital stay or total inpatient medical cost and clinical factors. The estimated odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each independent factor. To compare the central tendency of hospital stay of the lower postoperative albumin group versus the higher postoperative albumin group, as well as their medical costs, the Mann--Whitney *U* test was applied. A 2-tailed *p*-value \< 0.05 was considered significant. This study was approved by the Medical Ethics and Human Clinical Trial Committees at Chang Gung Memorial Hospital (Ethical Application Reference number:201900875B0). Patients' consent to review their medical records was not required by this hospital's committees because the patient data remained anonymous in this study.

Results {#sec010}
=======

A total of 213 patients were enrolled in this study. The clinical characteristics of the study patients are summarized in [Table 1](#pone.0236122.t001){ref-type="table"}. The patients' median age was 58 years (range: 35--88). The population included 201 (94.4%) male patients and 12 (5.6%) female patients. The ECOG performance status score in our cohort were all 0--1. The average BMI in this population was 21.86 kg/m^2^ (range: 14.2--32.83). The median length of hospital stay after surgery was 18 days (range: 7--70). The mean length of stay after surgery was 22.48 days, with a standard deviation of 12.49 days ([Fig 1](#pone.0236122.g001){ref-type="fig"}). The average total inpatient medical cost was 378,967 New Taiwan dollars (NTD) (range: 121,275--1,192,203 NTD ≈ 4,016--39,477 U.S. dollars ≈ 3,567--35,065 EUR (1 U.S. dollar is roughly equal to 30.2 NTD; 1 Euro is roughly equal to 34.0 NTD, according to the Bank of Taiwan, as of June 3, 2020).

![Variability in length of hospital stay.](pone.0236122.g001){#pone.0236122.g001}

10.1371/journal.pone.0236122.t001

###### Clinicopathological characteristics of 213 patients underwent total laryngectomy.

![](pone.0236122.t001){#pone.0236122.t001g}

  Characteristics                                                                        Value                            \%     
  -------------------------------------------------------------------------------------- -------------------------------- ------ ------
  Age Median(range), yr                                                                                                          
  Sex                                                                                    Male                             201    94.4
  Female                                                                                 12                               5.6    
  BMI [^a^](#t001fn001){ref-type="table-fn"} Average (range), Kg/m^2^                    21.86 (14.2 \~ 32.83)                   
  Median hospital length of stay (range), days                                           26 (10 \~ 107)                          
  Median postoperative hospital length of stay (range), days                             18 (7 \~ 70)                            
  Average of total inpatient medical cost (NTD [^b^](#t001fn002){ref-type="table-fn"})   378,967 (121,275 \~ 1,192,203)          
  Average preoperative serum hemoglobin (range), g/dL                                    12.901 (7.70 \~ 17.80)                  
  Average postoperative serum hemoglobin (range), g/dL                                   11.637 (8.35 \~ 15.40)                  
  Average preoperative serum albumin (range), g/dL                                       4.075 (2.70 \~ 4.95)                    
  Average postoperative serum albumin (range), g/dL                                      3.162 (2.00 \~ 4.20)                    
  Diabetes mellitus                                                                      27                               12.7   
  Liver cirrhosis                                                                        15                               7.0    
  Salvage surgery [\*](#t001fn003){ref-type="table-fn"}                                  No                               107    50.2
  Yes                                                                                    102                              47.9   
  Preoperative radiotherapy                                                              No                               126    59.2
  Yes                                                                                    87                               40.8   
  Cancer location                                                                        Oropharynx                       8      3.8
  Hypopharynx                                                                            112                              52.6   
  Larynx                                                                                 91                               42.7   
  Thyroid                                                                                2                                0.9    
  Neck dissection                                                                        No                               26     12.2
  Ipsilateral                                                                            102                              47.8   
  Bilateral                                                                              85                               40.0   
  Reason of surgery                                                                      Primary treatment                107    50.2
  Residual tumor                                                                         56                               26.3   
  Recurrent tumor                                                                        46                               21.6   
  Non-functional                                                                         4                                1.9    
  Wound closure                                                                          Primary closure                  48     22.5
  Free flap reconstruction                                                               165                              77.5   
  Design of free flap reconstruction                                                     Patch on                         101    47.4
  Tubing                                                                                 64                               30.1   
  Postoperative major wound infection                                                                                     57     

^a^BMI: Body mass index

^b^NTD: New Taiwan dollars; 1 U.S. dollar = 30.2 NTD (according to the Bank of Taiwan, as of June 3, 2020)

\* not include non-functional surgery

The average preoperative serum hemoglobin level was 12.901 g/dL (range: 7.7--17.8). The average postoperative serum hemoglobin level was 11.637 g/dL (range: 8.35--15.4). The average preoperative serum albumin level was 4.075 g/dL (range: 2.7--4.95). The average postoperative serum albumin level was 3.1 g/dL (range: 1.9--4.3). In this cohort, 27 patients (12.7%) had type II diabetes mellitus, and 15 patients (7.0%) had liver cirrhosis (14 patients had Child class A liver cirrhosis; the other patient had Child class B liver cirrhosis according to the Child-Pugh score).

The most common tumor subsite was the hypopharynx (n = 112, 52.6%), followed by the larynx (n = 91, 42.7%), base of tongue (n = 8, 3.8%), and thyroid (n = 2, 0.9%). All base of tongue cancers in this cohort were p16-negative tumors. Total laryngectomy which was performed among patients of base of tongue cancer or thyroid cancer was due to the direct involvement of larynx by tumor. The most histopathologic cancer type in this population was squamous cell carcinoma; the other 2 patients had papillary thyroid carcinoma.

There were 107 patients (50.2%) who underwent TL as the primary treatment, 102 patients (47.9%) who underwent salvage surgery for recurrent or persistent head and neck cancer after definite treatment, and 4 patients (1.9%) who underwent TL due to non-functional larynx secondary to previous organ preservation therapy. There were 87 patients (40.8%) who had prior RT history. The radiation technique for these patients was intensity-modulated radiation therapy (IMRT). The primary radiation dose was between 6,600 and 7,000 cGy (2 cGy/fraction).

In terms of operative method, ipsilateral neck dissection was performed in 102 patients (47.8%), 85 patients (40%) underwent bilateral neck dissections, and the other 26 patients (12.2%) didn't receive neck dissection because of negative nodal status after CCRT or RT. Among all patients, 165 (77.5%) underwent reconstruction with free flap transfer, including 160 anterolateral thigh and 5 anteromedial thigh flaps; 101 patients were reconstructed by the patch-on method; the other 64 patients were reconstructed by the flap-tubing method.

Mortality and immediate surgical complications {#sec011}
----------------------------------------------

Overall, 2 patients died in this hospitalization (2/213 = 0.9%). One patient had hypopharyngeal cancer (ypT4bN0M0), underwent salvage TL with free flap reconstruction for a persistent tumor after CCRT, and died on postoperative day 47 due to pharyngocutaneous fistula (PCF) related carotid blowout. The other patient, who had liver cirrhosis history (Child-Pugh classification A), underwent salvage TL for persistent supraglottic cancer (ypT2N3bM0), restaged according to the eighth edition of the AJCC system) with free flap reconstruction after the failure of CCRT. This patient developed postoperative pneumonia and wound infection with PCF and died on postoperative day 58 due to severe sepsis. There were 5 patients (5/165 = 3%) who had free flap failure and in whom plastic surgeons redid another free tissue transfer. Nine patients (9/165 = 5.45%) had anastomosis site leakage with an acute bleeding episode and required surgical exploration.

### Major wound infection {#sec012}

Major wound infection was defined as a wound that needed to be debrided and managed in the operating room. The incidence of postoperative major wound infection was 26.8% (57/213). Donor site wound infection or complication was not noted in this cohort.

Length of hospital stay {#sec013}
-----------------------

Several factors influencing prolonged postoperative LOS were selected for univariate analysis ([Table 2](#pone.0236122.t002){ref-type="table"}). Prior RT history (*p* = 0.007), free flap reconstruction for pharyngeal defect (*p* \< 0.001), postoperative lower serum albumin level (*p* = 0.025), and postoperative anemia (*p* = 0.04) were all significantly associated with higher probability of prolonged LOS. Logistic regression analysis was then performed, using these significant factors in univariate analysis. In this model, postoperative serum albumin level was a significant independent predictor of prolonged LOS (OR 2.477, 95% CI 1.189--5.163, *p* = 0.015). In addition, prior RT history significantly increased the probability of postoperative LOS as compared to no history of RT (OR 2.194, 95% CI 1.228--3.917, *p* = 0.08) ([Table 3](#pone.0236122.t003){ref-type="table"}).

10.1371/journal.pone.0236122.t002

###### Univariate analysis of factors impacting postoperative hospital stay and total inpatient medical cost.

![](pone.0236122.t002){#pone.0236122.t002g}

  Variable                                              Postoperative hospital stay(≧18 days)             *p*   Total inpatient medical cost (≧ 379,000 NTD[^b^](#t002fn003){ref-type="table-fn"})   *p*   
  ----------------------------------------------------- ------------------------------------------------- ----- ------------------------------------------------------------------------------------ ----- ---------
  Cancer location                                       Oropharynx[\*](#t002fn001){ref-type="table-fn"}   \-    0.521                                                                                \-    0.807
  Hypopharynx                                           58                                                40                                                                                               
  Larynx                                                43                                                31                                                                                               
  Others[\*](#t002fn001){ref-type="table-fn"}           \-                                                \-                                                                                               
  Salvage surgery                                       No                                                46    0.062                                                                                35    0.327
  Yes                                                   57                                                40                                                                                               
  Preoperative radiotherapy                             No                                                53    0.007                                                                                40    0.203
  Yes                                                   53                                                35                                                                                               
  Neck dissection                                       No                                                11    0.417                                                                                6     0.167
  Yes                                                   95                                                69                                                                                               
  Reason of surgery                                     Primary treatment                                 46    0.169                                                                                35    0.619
  Residual tumor                                        32                                                22                                                                                               
  Recurrent tumor                                       25                                                18                                                                                               
  Non-functional[\*](#t002fn001){ref-type="table-fn"}   \-                                                \-                                                                                               
  Wound closure                                         Primary closure                                   10    \<0.001                                                                              4     \<0.001
  Flap reconstruction                                   96                                                71                                                                                               
  Design of free flap reconstruction                    Patch on                                          55    0.223                                                                                38    0.078
  Tubing                                                41                                                33                                                                                               
  Preoperative albumin level (g/dL)                     \< 3.5                                            9     0.144                                                                                8     0.04
  ≧ 3.5                                                 81                                                56                                                                                               
  Postoperative albumin level (g/dL)                    \< 3.5                                            88    0.025                                                                                70    \<0.001
  ≧ 3.5                                                 14                                                3                                                                                                
  BMI[^a^](#t002fn002){ref-type="table-fn"} (Kg/m2)     \< 23                                             73    0.303                                                                                54    0.069
  ≧ 23                                                  31                                                18                                                                                               
  Liver cirrhosis                                       No                                                95    0.058                                                                                66    0.037
  Yes                                                   11                                                9                                                                                                
  Diabetes mellitus                                     No                                                93    0.857                                                                                66    0.827
  Yes                                                   13                                                9                                                                                                
  Preoperative hemoglobin level (g/dL)                  \< 13                                             53    0.946                                                                                43    0.127
  ≧ 13                                                  53                                                32                                                                                               
  Postoperative hemoglobin level (g/dL)                 \< 13                                             96    0.04                                                                                 69    0.05
  ≧ 13                                                  10                                                6                                                                                                

\* subgroup which not include for analysis

^a^BMI: body mass index

^b^NTD: New Taiwan dollars; 1 U.S. dollar = 30.2 NTD (according to the Bank of Taiwan, as of June 3, 2020)

10.1371/journal.pone.0236122.t003

###### Multiple regression analysis of factors impacting longer postoperative hospitalization (≧ 18 days) of all patients.
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  Factor                         Odds ratio   95% Confident Interval   *p* value      
  ------------------------------ ------------ ------------------------ ----------- -- ------
  Postoperative Albumin (g/dL)   ≧ 3.5        1                                       .015
  \< 3.5                         2.477        1.189                    5.163          
  Preoperative radiotherapy      No           1                                       .008
  Yes                            2.194        1.228                    3.917          

Inpatient medical cost {#sec014}
----------------------

The association between clinical variables and inpatient medical cost is shown in [Table 2](#pone.0236122.t002){ref-type="table"}. Free flap reconstruction for pharyngeal defect (*p* \< 0.001), preoperative lower serum albumin level (*p* = 0.04), postoperative lower serum albumin level (*p* \< 0.001), and history of liver cirrhosis (*p* = 0.037) were all significantly associated with higher probability of high inpatient medical cost. Logistic regression analysis was then performed, using these significant factors in univariate analysis. In this model, postoperative hypoalbuminemia was a significant independent predictor of higher inpatient medical cost (OR 6.671, 95% CI 1.927--23.093, *p* = 0.003). In addition, a wound that needed free flap reconstruction significantly increased the probability of high inpatient medical cost as compared to the group whose wounds were closed primarily (OR 5.011, 95% CI 1.657--15.156, *p* = 0.04) ([Table 4](#pone.0236122.t004){ref-type="table"}).

10.1371/journal.pone.0236122.t004

###### Multiple regression analysis of factors impacting higher total inpatient medical cost (≧ 379,000 NTD[a](#t004fn001){ref-type="table-fn"}).
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  Factor                         Odds ratio        95% Confident Interval   *p* value      
  ------------------------------ ----------------- ------------------------ ----------- -- ------
  Postoperative Albumin (g/dL)   ≧ 3.5             1                                       .003
  \< 3.5                         6.671             1.927                    23.093         
  Wound closure                  Primary closure   1                                       .004
  flap reconstruction            5.011             1.657                    15.156         

^a^ NTD: New Taiwan dollars; 1 U.S. dollar = 30.2 NTD (according to the Bank of Taiwan, as of June 3, 2020)

Patients with postoperative hypoalbuminemia had significantly longer postoperative LOS than those patients with higher postoperative albumin levels (≧3.5 g/dL; Mann-Whitney test, *p* = 0.001). On average, patients with lower postoperative albumin levels (\<3.5 g/dL) had 23.49 days of hospitalization after surgery, which is 35% more days compared to patients with higher postoperative albumin levels (≧3.5 g/dL), whose LOS was 17.39 days on average. As the length of hospitalization increased, the patient's total inpatient medical bill increased correspondingly. The total inpatient medical costs of patients with lower postoperative albumin levels (\<3.5 g/dL) were significantly higher than those of patients with higher postoperative albumin levels (≧3.5 g/dL; Mann-Whitney test, *p* \< 0.001). Patients with lower postoperative albumin levels (\<3.5 g/dL) had an average medical cost of 404,875 NTD (about 13,406 U.S. dollars), which is 48% higher than that of patients with higher postoperative albumin levels (≧3.5 g/dL), who had an average cost of 272,847 NTD (about 9,035 U.S. dollars) ([Table 5](#pone.0236122.t005){ref-type="table"}).

10.1371/journal.pone.0236122.t005

###### Comparison of central tendency between different postoperative albumin level among postoperative length of hospital stay and total inpatient medical cost.
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                             Postoperative length of hospital stay (days)   Total inpatient mediation cost (NTD [^a^](#t005fn001){ref-type="table-fn"})                         
  -------------------------- ---------------------------------------------- ----------------------------------------------------------------------------- --------------------- --------------------
  Number                     164                                            41                                                                            164                   41
  Range                      \[8, 69\]                                      \[7, 40\]                                                                     \[136725, 1192203\]   \[121275, 454668\]
  Mean                       23.49                                          17.39                                                                         404875                272847
  Mean rank                  110.00                                         75.00                                                                         114.28                57.87
  Mann-Whitney U statistic   2214.0                                         1511.5                                                                                              
  *p* value                  0.001                                          \<0.001                                                                                             

^a^ NTD: New Taiwan dollars; 1 U.S. dollar = 30.2 NTD (according to the Bank of Taiwan, as of June 3, 2020)

Discussion {#sec015}
==========

In the previous studies, BuSaba and Schaumberg described multiple factors, such as several comorbid conditions, longer operative time, intraoperative blood transfusion and postoperative complications, were significantly associated with increased length of stay in elective major head and neck surgeries \[[@pone.0236122.ref006]\]. In different laryngeal preservation treatments in glottic Cancer, Mandelbaum et al. had also found that open surgery, endoscopic surgery was associated with reduced hospital charges than primary chemoradiation therapy \[[@pone.0236122.ref007]\]. Dombrée et al had studied the surgical charge by different surgical methods for total laryngectomy, which demonstrated the surgical cost was more expensive in TORS (the average surgical cost was 6,767 Euro) than open approach (the average surgical cost was 3,581 Euro) \[[@pone.0236122.ref008]\].

In our cohort, almost 40% of patients had had history of prior radiation therapy. Major wound infection occurred in 26.8% of patients. We found that length of stay was highly associated with postoperative hypoalbuminemia and history of prior radiation therapy. Lastly, high inpatient medical cost was significantly associated with postoperative hypoalbuminemia and wound closure by free flap for neopharyngeal defect.

The lengths of postoperative hospital stay could be various in different countries due to the distinct type of funding in each country and the various post-hospitalization structures \[[@pone.0236122.ref009]\]. Most patients discharged from the hospital usually going back home in Taiwan directly.

Goepfert et al. demonstrated that preoperative RT significantly influenced the length of hospital stay \[[@pone.0236122.ref002]\]. Tissue blood flow dysfunction may occur after radiotherapy and lead to poor wound healing status \[[@pone.0236122.ref010]\]. Among patients who diagnosed with HNSCC and need surgical salvage after definite radiotherapy, as Sassler et al. reported in their study, the incidence of wound complications was up to 64% \[[@pone.0236122.ref011]\]. In the RTOG Trial 91--11, PCF rates after salvage total laryngectomy ranged from 15 to 30% \[[@pone.0236122.ref012]\]. Other studies showed that PCF rates were relatively high, range from 15 to 50% for salvage surgery after definite radiotherapy or chemoradiotherapy \[[@pone.0236122.ref005], [@pone.0236122.ref011], [@pone.0236122.ref012]\]. Our cohort also revealed similar results: that history of radiotherapy increased the wound infection rate and prolonged hospital stays.

Another possible factor increased the rate of wound infection and PCF formation may be low thyroid function status perioperatively, especially in patients had prior RT history. In previous study, Rosko et al. described postoperative hypothyroidism independently predicts postoperative wound-healing complications including PCF formation in patients who underwent salvage total laryngectomy after RT/CRT \[[@pone.0236122.ref013]\]. In our cohort, only 41 patients (41/213 = 19.2%) had checked thyroid function status in postoperative period. Fifteen patients were in clinical hypothyroidism, six patients were in subclinical hypothyroidism and other twenty patients were in euthyroid status. All patients diagnosed as hypothyroidism after surgery would be immediately treated with thyroxine according to our guideline. The subgroup analysis didn't show significance in the association between thyroid function status and clinical outcomes, including postoperative hospital stay and inpatient medical cost.

The management of pharyngeal mucosa defect after TL depends on the width of residual pharyngeal wall mucosa. If it is not adequate for primary closure or the circulation over the pharyngeal mucosa is poor after RT/CRT, reconstruction with local flap or free flap is inevitable. In turn, this prompts a lengthier hospital stay, higher medical expenses, and more potential morbidities, according to the data from this cohort.

Malnutrition is a well-known factor that related to poor wound healing. Hypoalbuminemia, as one of marker of malnutrition, also indicates prolonged hospital stay \[[@pone.0236122.ref014], [@pone.0236122.ref015]\]. In the present study, however, postoperative albumin level had a stronger association with prolonged hospital stay than any other nutrition-related marker. In the Takahara's study, postoperative hypoalbuminemia has a stronger association with longer hospital stay than other nutrition-related marker \[[@pone.0236122.ref016]\]. Our previous studies showed similar results: that postoperative hypoalbuminemia is a useful indicator of the development of postoperative complications and prolonged postoperative hospital stay among patients who underwent tumor excision and free flap reconstruction for an advanced stage of HNSCC \[[@pone.0236122.ref017]\].

A locally advanced tumor stage over the larynx or hypopharynx may cause poor nutrition status before treatment. In addition, previous RT/CRT for locally advanced tumors may further decrease the nutrition reserve after this treatment cycle. This study demonstrated that lower albumin status before surgical intervention would increase the medical cost, complications after operation, and the hospital stay.

There are several limitations that should be addressed in the current study. First, this is a retrospective, single‐institute study and selection bias in patient and data collection may happen. Second, due to the different indication of surgery, cancer location, histological type of cancer, and prior radiotherapy or not, the heterogeneity between patients was still high. Third, another important weak point was lack of thyroid function status in most our patients in our cohort.

Conclusions {#sec016}
===========

Previous RT history and postoperative lower albumin level show impacts on the length of hospital stay. In addition, the application of free flap reconstruction for pharyngeal defect and postoperative lower albumin status increase the inpatient medical cost among patients who undergo total laryngectomy for laryngeal cancer/hypopharyngeal cancer. In our cohort, the inpatient medical cost was 48% higher and length of stay after surgery was 35% longer among hypoalbuminemia patients.

Supporting information {#sec017}
======================

###### Analytical dataset used in the study.

<https://doi.org/10.6084/m9.figshare.12568565.v1>.

(XLSX)

###### 

Click here for additional data file.

10.1371/journal.pone.0236122.r001
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2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: A well-written article.

Results are very difficult to extrapolate, because as the authors highlight cost related to surgery varies according to each country.

However, add interesting information in order to increase savings related to healthcare.

Reviewer \#2: please see attachment

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Carlos M Chiesa-Estomba

Reviewer \#2: Yes: Jerome R. Lechien

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]
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We sincerely appreciate the constructive comments by your esteemed reviewers and we believe it has enhanced the clarity of our work. We have made the changes accordingly, along with the point-by-point response below. Once again we thank the editorial board of PLOS ONE and we hope to see our work published in this prestigious journal in the near future.

Many thanks

Reply to reviewers' comments

To Reviewer \#1:

A well-written article.

Results are very difficult to extrapolate, because as the authors highlight cost related to surgery varies according to each country.

However, add interesting information in order to increase savings related to healthcare.

Response:

We thank the reviewer for this great point. It is true that different health care systems in different countries will affect the length of postoperative hospital stay and inpatient medical expenses after total laryngectomy. We add this in the discussion. (line 241-242)

 

To Reviewer \#2:

The authors investigated the predictive factors of PO hospital stay & medical cost in patients who benefited from TL. They identified several factors associated with the PO hospital stay or medical cost, including postoperative Hb level, albumin, preoperative RT (salvage TL), cirrhosis history or wound closure method. The study is well-conducted and designed and helpful for OTOHNS surgeons. The paper is short and to-the-point, which is particularly important for a potential publication in the journal.

Some point has however been addressed to improve the manuscript.

Abstract:

1\. Develop the method section: state the studied outcomes (preop RT, etc.).

Response: We thank the reviewer for this suggestion. We added this description about studied outcomes in section of abstract. (line 7 - 12)

Introduction:

2\. To the point, well organized.

Response: We thank the reviewer for your appreciation.

Methods:

3\. What were your indication to make a flap and which flap were used ? Specify the exclusion criteria.

Response: Free flap transfer for pharyngeal defect reconstruction after total laryngectomy would be performed if pharyngeal defect couldn't primarily close without tension. The flap was most often harvested from the anterolateral thigh (n=160) followed by the anteromedial thigh (n=5) in our cohort. Patients who received partial laryngectomy or partial laryngopharyngectomy or patient didn't receive total laryngectomy surgical procedure in our hospital would be excluded from our study. We have also updated the manuscript in the section of Method. (line 67 - 71 and line 153 - 156).

4\. Line 80: you already define BMI in the abbreviation (line 70), just keep in this line BMI.

Response: We thank the reviewer for this insightful observation. We had change word from "Body mass index (BMI, kg/m2)" to "BMI". (line 85)

Results:

5\. line 114 = the cost is presented in Taiwan money and U.S. dollar. Please, present in the brackets the Euro value for European Physicians. Thus, you cover both U.S. and Europe.

Response: Thank you very much for this useful recommendation. We had added the information of Taiwan Dollar to Euro Exchange Rate in our revised manuscript. (line 122 - 123)

6\. Briefly specify the RT protocol (number of Gy, fraction, etc.)

Response: We thank the reviewer for this suggestion. The radiation technique for these patients was intensity-modulated radiation therapy (IMRT). The primary radiation dose was between 6,600 and 7,000 cGy (2 cGy/fraction). We had added this description in the section of Result. (line 149 - 150)

Discussion:

7\. Another biological point that is important to consider is the thyroid status. In practice, we usually observed that hypothyroidism patients have wound healing disorder and longer hospital stay. The lack of consideration of this point is a limitation that has to be addressed.

Response: We thank the reviewer for this great point. In previous study, Rosko et al. described postoperative hypothyroidism independently predicts postoperative wound-healing complications including pharyngocutaneous fistula formation in patients who underwent salvage total larygectomy \[1\]. In our cohort, most patients lack of thyroid function status in laboratory exam before/after total laryngectomy. Only 10 patients (10/213=4.7%) had thyroid function status before total laryngectomy and all of them were in euthyroid status. In postoperative period, 41 patients (41/213=19.2%) had checked thyroid function status during the hospitalization. Of them, 20 patients were in euthyroid status, 15 patients were in clinical hypothyroidism (decreased serum free T4 level and elevated serum TSH level) and 6 patients were in subclinical hypothyroidism (elevated serum TSH level and normal serum free T4 level). All patients diagnosed with hypothyroidism had been immediately treated with thyroxine according to our guideline. We have performed additional subgroup analyses between different postoperative thyroid function status. The association between thyroid function status and our interested outcome, including postoperative hospital stay and inpatient medical cost was showed in Table A. The univariate analysis didn't show significance. The reason may be (1) the small number (n=41) in this analysis and (2) temporary low thyroid functional level postoperatively, because thyroxine supplement had been prescribed after hypothyroidism diagnosed. We have also updated the manuscript to reflect these findings. (line 253 -- 263, 286 -- 287)

8\. Develop the limitation paragraph, heterogeneity between patients (indication/tumor localization, RT) etc. that may consist of heterogeneity in the study. The inclusion of non-SCC (papillary thyroid) is another bias.

Response: We thank the reviewer for this suggestion. We had added the limitation paragraph about this study in section of discussion (line 283 -- 287)

Conclusion:

9\. Remove "in total". The sentence could be: Previous RT history and postoperative lower albumin level significantly impact the length of hospital stay.

Response: We thank the reviewer for this suggestion. We had changed this sentence in section of conclusion to "Previous RT history and postoperative lower albumin level significantly impact the length of hospital stay." (line 290)

Reference:

1\. Rosko AJ, Birkeland AC, Bellile Eet al. Hypothyroidism and Wound Healing After Salvage Laryngectomy. Ann Surg Oncol 2018; 25:1288-1295.

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0236122.r003

Decision Letter 1

Cammaroto

Giovanni

Academic Editor

© 2020 Giovanni Cammaroto

2020

Giovanni Cammaroto

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

30 Jun 2020

Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis

PONE-D-20-17243R1

Dear Dr. Chien,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Giovanni Cammaroto

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0236122.r004

Acceptance letter

Cammaroto

Giovanni

Academic Editor

© 2020 Giovanni Cammaroto

2020

Giovanni Cammaroto

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

6 Jul 2020

PONE-D-20-17243R1

Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis

Dear Dr. Chien:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Giovanni Cammaroto

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
